MENU
+Compare
INCY
Stock ticker: NASDAQ
AS OF
Apr 1 closing price
Price
$60.91
Change
+$0.36 (+0.59%)
Capitalization
11.79B

INCY Incyte Corp Forecast, Technical & Fundamental Analysis

Incyte focuses on the discovery and development of small-molecule drugs... Show more

Industry: #Biotechnology
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for INCY with price predictions
Apr 01, 2025

INCY in downward trend: price dove below 50-day moving average on March 03, 2025

INCY moved below its 50-day moving average on March 03, 2025 date and that indicates a change from an upward trend to a downward trend. In of 40 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for INCY turned negative on March 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for INCY crossed bearishly below the 50-day moving average on March 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INCY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INCY entered a downward trend on March 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where INCY's RSI Indicator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where INCY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 01, 2025. You may want to consider a long position or call options on INCY as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INCY advanced for three days, in of 301 cases, the price rose further within the following month. The odds of a continued upward trend are .

INCY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INCY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.399) is normal, around the industry mean (13.458). INCY has a moderately high P/E Ratio (403.667) as compared to the industry average of (64.587). Projected Growth (PEG Ratio) (0.387) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (3.006) is also within normal values, averaging (251.391).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

INCY is expected to report earnings to fall 28.67% to $1.02 per share on May 06

Incyte Corp INCY Stock Earnings Reports
Q1'25
Est.
$1.02
Q4'24
Missed
by $0.08
Q3'24
Beat
by $0.04
Q2'24
Missed
by $2.69
Q1'24
Missed
by $0.18
The last earnings report on February 10 showed earnings per share of $1.43, missing the estimate of $1.51. With 2.58M shares outstanding, the current market capitalization sits at 11.79B.
A.I. Advisor
published General Information

General Information

a developer of drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1801 Augustine Cut-Off
Phone
+1 302 498-6700
Employees
2524
Web
https://www.incyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PPT3.640.03
+0.83%
Putnam Premier Income Trust
IPO37.820.27
+0.72%
Renaissance IPO ETF
PXH21.810.07
+0.30%
Invesco RAFI Emerging Markets ETF
IEFA75.840.19
+0.25%
iShares Core MSCI EAFE ETF
AHYB45.620.10
+0.22%
American Century® Select High Yield ETF

INCY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INCY has been loosely correlated with AXON. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if INCY jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCY
1D Price
Change %
INCY100%
+0.59%
AXON - INCY
39%
Loosely correlated
+2.90%
PLRX - INCY
35%
Loosely correlated
+1.48%
REGN - INCY
33%
Loosely correlated
-2.72%
SRPT - INCY
33%
Poorly correlated
-2.99%
BMRN - INCY
32%
Poorly correlated
-3.89%
More